3 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow Robert Ferris: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA Semi-allogenic human fibroblast (MRC-5) transfected with DNA - Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 1 | Withdrawn | Robert Ferris | 2016-09-01 | 2017-09-07 | |
| ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma Cetuximab, Surgery, Post-surgical radiation - Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Completed | Robert Ferris | 40 | 2011-02-01 | 2018-08-16 |
| Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer Panitumumab, Cisplatin, Radiation Therapy - Cancer of Head, Cancer of Head and Neck | Phase 2 | Completed | Robert Ferris | 46 | 2007-11-01 | 2017-10-03 |
| Vaccine Therapy in Treating Patients With Head and Neck Cancer mutant p53 peptide pulsed dendritic cell vaccine, tetanus toxoid helper peptide, adjuvant therapy - Head and Neck Cancer | Phase 1 | Completed | Robert Ferris | 17 | 2005-09-01 | 2016-04-18 |
Head and Neck Neoplasms (3) · Squamous Cell Carcinoma of Head and Neck (3) · Carcinoma (2) · Carcinoma, Squamous Cell (1) · Tongue Neoplasms (1)
Cisplatin (2) · Carboplatin (1) · Cetuximab (1) · Chemotherapy, Adjuvant (1) · DNA (1) · Panitumumab (1) · Radiotherapy (1) · Surgical Procedures, Operative (1)
United States (4)
Rober L Ferris, MD, PhD (1) · Robert L Ferris, MD (1) · Robert L. Ferris, MD, PhD (1)